Gispen-de Wied C - Search Results

1

Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review.

Crijns HJ, Straus SM, Gispen-de Wied C, de Jong-van den Berg LT. Crijns HJ, et al. Br J Dermatol. 2011 Feb;164(2):238-44. doi: 10.1111/j.1365-2133.2010.09976.x. Br J Dermatol. 2011. PMID: 20716214 Free article. Review.

2

The distribution of congenital anomalies within the VACTERL association among tumor necrosis factor antagonist-exposed pregnancies is similar to the general population.

Crijns HJ, Jentink J, Garne E, Gispen-de Wied CC, Straus SM, de Jong-van den Berg LT; EUROCAT Working Group. Crijns HJ, et al. J Rheumatol. 2011 Sep;38(9):1871-4. doi: 10.3899/jrheum.101316. Epub 2011 Jul 1. J Rheumatol. 2011. PMID: 21724702

3

Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies.

Crijns I, Straus S, Luteijn M, Gispen-de Wied C, Raine J, de Jong-van den Berg L. Crijns I, et al. Drug Saf. 2012 Jan 1;35(1):27-32. doi: 10.2165/11595570-000000000-00000. Drug Saf. 2012. PMID: 22050373

4

Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study.

Crijns HJ, van Rein N, Gispen-de Wied CC, Straus SM, de Jong-van den Berg LT. Crijns HJ, et al. Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1060-6. doi: 10.1002/pds.3200. Epub 2012 Jan 6. Pharmacoepidemiol Drug Saf. 2012. PMID: 22228673

5

Insomnia medication: do published studies reflect the complete picture of efficacy and safety?

Mattila T, Stoyanova V, Elferink A, Gispen-de Wied C, de Boer A, Wohlfarth T. Mattila T, et al. Eur Neuropsychopharmacol. 2011 Jul;21(7):500-7. doi: 10.1016/j.euroneuro.2010.10.005. Epub 2010 Nov 16. Eur Neuropsychopharmacol. 2011. PMID: 21084176

6

The EU paediatric regulation: effects on paediatric psychopharmacology in Europe.

Stoyanova-Beninska VV, Wohlfarth T, Isaac M, Kalverdijk LJ, van den Berg H, Gispen-de Wied C. Stoyanova-Beninska VV, et al. Eur Neuropsychopharmacol. 2011 Aug;21(8):565-70. doi: 10.1016/j.euroneuro.2010.06.011. Epub 2010 Jul 10. Eur Neuropsychopharmacol. 2011. PMID: 20621456 Review.

7

Regulatory scientific advice on non-inferiority drug trials.

Wangge G, Putzeist M, Knol MJ, Klungel OH, Gispen-De Wied CC, de Boer A, Hoes AW, Leufkens HG, Mantel-Teeuwisse AK. Wangge G, et al. PLoS One. 2013 Sep 5;8(9):e74818. doi: 10.1371/journal.pone.0074818. eCollection 2013. PLoS One. 2013. PMID: 24040346 Free PMC article.

8

Commentary on 'Gender differences in clinical registration trials; is there a real problem?' by Labots et al.

Gispen-de Wied C, de Boer A. Gispen-de Wied C, et al. Br J Clin Pharmacol. 2018 Aug;84(8):1639-1640. doi: 10.1111/bcp.13620. Epub 2018 May 31. Br J Clin Pharmacol. 2018. PMID: 29704271 Free PMC article. No abstract available.

9

Future of the drug label: Perspectives from a multistakeholder dialogue.

Gispen-de Wied CC, Weemers J, Boon W, Mol PGM, Stolk P. Gispen-de Wied CC, et al. Br J Clin Pharmacol. 2019 Oct;85(10):2442-2445. doi: 10.1111/bcp.14070. Epub 2019 Aug 5. Br J Clin Pharmacol. 2019. PMID: 31317570 Free PMC article.

10

Antidepressants use in children and adolescents and the risk of suicide.

Wohlfarth TD, van Zwieten BJ, Lekkerkerker FJ, Gispen-de Wied CC, Ruis JR, Elferink AJ, Storosum JG. Wohlfarth TD, et al. Eur Neuropsychopharmacol. 2006 Feb;16(2):79-83. doi: 10.1016/j.euroneuro.2005.10.004. Epub 2005 Nov 18. Eur Neuropsychopharmacol. 2006. PMID: 16298514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page